Recursion Pharmaceuticals, Inc. (RXRX)
4.73
-0.23
(-4.64%)
USD |
NASDAQ |
Jan 23, 16:00
4.72
-0.01
(-0.21%)
After-Hours: 20:00
Recursion Pharmaceuticals Research and Development Expense (TTM): 433.37M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| XOMA Royalty Corp. | 2.295M |
| Mirum Pharmaceuticals, Inc. | 178.77M |
| Hims & Hers Health, Inc. | -- |
| ACADIA Pharmaceuticals, Inc. | 344.78M |
| Plus Therapeutics, Inc. | 7.624M |